| Biopharmaceutical plants accounts a major amount of | | | | development procedure starts from incorporation of |
| production of all medicines required by the customers. | | | | DNA of intended molecule into the specified host |
| But the major challenge faced by them is that they | | | | plant. This process replicates the target molecule |
| are using resources belonging to animal origin. To | | | | during its growth. During the refinement and revival |
| meet the growing demand of market, therapeutic | | | | process, antibodies are produced in the host plant. |
| proteins obtained from animal tissues are not | | | | This procedure has proved its proficiency and is |
| sufficient. Substitutes for this are to be searched for | | | | eye-catching for pharmaceutical industries. |
| the further expansion of Pharmaceutical engineering. | | | | Biopharmaceuticals is able to meet the growing |
| | | | | demand because of the efficient methods like |
| The solution for this challenge is found out by | | | | storing, processing and existing crop harvesting. |
| modern biotechnology. They have created genetically | | | | |
| engineered plants which has the ability to substitute | | | | Use of genetically engineered plant for the |
| animal resources. These genetically engineered plants | | | | manufacture of drugs is a recent development of |
| have the capability of producing affordable medicines | | | | Biotechnology but it has the potential to take the |
| which can meet the growing demand. They can | | | | world of Pharmaceutical engineering to new heights. |
| produce recombinant proteins which includes | | | | It has all the qualities indispensable for large scale |
| cytokines, blood product alternatives, mammalian | | | | drug development like less preliminary investment, |
| antibodies, vaccines and several curative agents. | | | | simple recuperation, safety, proper purification etc. It |
| Biotechnology has contributed a lot to Pharmaceutical | | | | has increased the production to many folds. Yet |
| engineering. | | | | Biopharmaceutical plants cannot completely depend |
| | | | | upon genetically engineered plants for drug |
| Proper gene expression system and host selection is | | | | development as this technology is very new and not |
| mandatory for biopharmaceutical plants. The drug | | | | completely expanded. |